Ocuphire Pharma Analysis

Ocuphire Stock Analysis Notes

The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ocuphire Pharma recorded a loss per share of 0.54. The entity last dividend was issued on the 6th of November 2020. The firm had 1:4 split on the 6th of November 2020. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan. Ocuphire Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. To find out more about Ocuphire Pharma contact MBA MD at (248) 957-9024 or learn more at https://www.ocuphire.com.

Ocuphire Pharma Investment Alerts

Ocuphire Pharma Upcoming and Recent Events

Ocuphire Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.84 M.

Ocuphire Profitablity

The company has Profit Margin (PM) of (0.86) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.49.

Ocuphire Pharma Insider Trading Activities

Ocuphire Pharma Outstanding Bonds

Ocuphire Pharma Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ocuphire Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ocuphire shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Ocuphire Pharma. By using and applying Ocuphire Stock analysis, traders can create a robust methodology for identifying Ocuphire entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.